22
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

CT Quantitation and Prediction of the Risk of Type 2 Diabetes Mellitus in Non-Obese Patients with Pancreatic Fatty Infiltration

, ORCID Icon, , , , , , , ORCID Icon & show all
Pages 2619-2625 | Received 27 Dec 2023, Accepted 15 Jun 2024, Published online: 02 Jul 2024

References

  • Toplak H, Leitner DR, Harreiter J, et al. „Diabesity“–adipositas und typ-2-diabetes (update 2019). Wien Klin Wochenschr. 2019;131:71–76. doi:10.1007/s00508-018-1418-9
  • Kashima S, Inoue K, Matsumoto M, Akimoto K. Prevalence and characteristics of non-obese diabetes in Japanese men and women: the yuport medical checkup center study. J Diabetes. 2015;7(4):523–530. doi:10.1111/1753-0407.12213
  • Tang Z, Fang Z, Huang W, et al. Non-obese diabetes and its associated factors in an underdeveloped area of South China, Guangxi. Int J Environ Res Public Health. 2016;13(10):976. doi:10.3390/ijerph13100976
  • Xinghui L, Yandi W, Jingjing Z, et al. Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus. Theranostics. 2020;10(6):2675–2695. doi:10.7150/thno.40735
  • Rattarasarn C. Dysregulated lipid storage and its relationship with insulin resistance and cardiovascular risk factors in non-obese Asian patients with type 2 diabetes. Adipocyte. 2018;7(2):71–80. doi:10.1080/21623945.2018.1429784
  • Fingeret M, Marques-Vidal P, Vollenweider P. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese. Nutr Metab Cardiovasc Dis. 2018;28(10):1036–1044. doi:10.1016/j.numecd.2018.06.011
  • Racette SB, Weiss EP, Hickner RC, et al. Modest weight loss improves insulin action in obese African Americans. Metabolism. 2005;54(7):960–965. doi:10.1016/j.metabol.2005.02.013
  • Sakitani K, Enooku K, Kubo H, et al. Clinical characteristics of patients with diabetes mellitus and fatty liver diagnosed by liver/spleen Hounsfield units on CT scan. J Int Med Res. 2017;45:1208–1220. doi:10.1177/0300060517707672
  • Vendrik KEW, Tonneijck L, Muskiet MHA, et al. Pancreatic steatosis is not associated with exocrine pancreatic function in overweight type 2 diabetes patients. Pancreas. 2017;46:e75–e76. doi:10.1097/mpa.0000000000000893
  • Dong Z, Luo YJ, Zhang ZW, et al. MR quantification of total liver fat in patients with impaired glucose tolerance and healthy subjects. PLoS One. 2014;9:e111283. doi:10.1371/journal.pone.0111283
  • Martin S, Sorokin EP, Thomas EL, et al. Estimating the effect of liver and pancreas volume and fat content on risk of diabetes: a Mendelian randomization study. Diabetes Care. 2022;45(2):460–468. doi:10.2337/dc21-1262
  • Yamazaki H, Tauchi S, Wang J, et al. Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study. J Gastroenterol. 2020;55:712–721. doi:10.1007/s00535-020-01683-x
  • Wagner R, Jaghutriz BA, Gerst F, et al. Pancreatic steatosis associates with impaired insulin secretion in genetically predisposed individuals. J Clin Endocrinol Metab. 2020;105:3518–3525. doi:10.1210/clinem/dgaa435
  • Kim SY, Kim H, Cho JY, et al. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology. 2014;271:104–112. doi:10.1148/radiol.13122883
  • Lim S, Bae JH, Chun EJ, et al. Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol. 2014;51:739–748. doi:10.1007/s00592-014-0581-3
  • Lim EL, Hollingsworth KG, Aribisala BS, et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–2514. doi:10.1007/s00125-011-2204-7
  • Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Very low calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care. 2016;39:808–865. doi:10.2337/dc18-er06
  • Steven S, Hollingsworth KG, Small PK, et al. Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes. Diabetes Care. 2016;39:158–165. doi:10.2337/dc15-0750
  • Wong VWS, Wong GLH, Yeung DKW, et al. Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol. 2014;109:589–597. doi:10.1038/ajg.2014.1
  • Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, et al. Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for β cell recovery. Cell Metab. 2018;28(4):547–556.e3. doi:10.1016/j.cmet.2018.07.003
  • Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev. 2010;26:200–205. doi:10.1002/dmrr.1073
  • Kim MK, Chun HJ, Park JH, et al. The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes. Diabet Res Clin Pract. 2014;106:590–596. doi:10.1016/j.diabres.2014.09.005
  • Zhang LF, Wang ZW, Wang X, et al. Prevalence of overweight and obesity in China: results from a cross-sectional study of 441 thousand adults, 2012–2015. Obes Res Clin Pract. 2020;14:119–126. doi:10.1016/j.orcp.2020.02.005
  • Narisada A, Shibata E, Hasegawa T, et al. Sex differences in the association between fatty liver and type 2 diabetes incidence in non-obese Japanese: a retrospective cohort study. J Diabetes Investig. 2021;12(8):1480–1489. doi:10.1111/jdi.13496